Skip to main navigation Skip to search Skip to main content

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

  • G. Jerusalem
  • , S. Farah
  • , A. Courtois
  • , J. Chirgwin
  • , S. Aebi
  • , P. Karlsson
  • , P. Neven
  • , E. Hitre
  • , M.P. Graas
  • , E. Simoncini
  • , E. Abdi
  • , C. Kamby
  • , A. Thompson
  • , S. Loibl
  • , J. Gavilá
  • , K. Kuroi
  • , C. Marth
  • , B. Müller
  • , S. O'Reilly
  • , A. Gombos
  • T. Ruhstaller, H.J. Burstein, M. Rabaglio, B. Ruepp, K. Ribi, G. Viale, R.D. Gelber, A.S. Coates, S. Loi, A. Goldhirsch, M.M. Regan, M. Colleoni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1256-1266
Number of pages11
JournalAnnals of Oncology
Volume32
Issue number10
Publication statusPublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this